Abstract. T he a nti-inf la m mator y mecha n ism of 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone (5HHMF), a polyhydroxyflavone isolated from the marine algae Hizikia fusiforme, was investigated in RAW 264.7 murine macrophage cells. Western blot and reverse transcriptase PCR analyses indicated that adding 5HHMF to cultured cells significantly reduced the production of nitric oxide and prostaglandin E 2 and downregulated inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. In addition, 5HHMF inhibited the release of pro-inflammatory cytokines, such as tumor necrosis factor-α and interleukin-1β, and decreased the transcriptional levels. In particular, 5HHMF significantly inhibited the LPS-induced nuclear factor-κB (NF-κB) translocation from the cytosol to the nucleus, which was associated with the abrogation of inhibitory IκBα degradation and subsequent decreases in nuclear p65 levels. In conclusion, these results suggested that the anti-inflammatory activities of 5HHMF may be attributed to the inhibition of iNOS, COX-2 and cytokine expression by attenuating NF-κB activation via IκBα degradation in macrophages.
Introduction
Inflammation is crucial in mammalian physiology and is a hallmark of many human diseases, including atherosclerosis, autoimmune disorders, diabetes, chronic infection and cancer (1) . In the presence of stimuli such as lipopolysaccharide (LPS), activated macrophages produce several inflammatory mediators, including nitric oxide (NO) and prostaglandin E 2 (PGE 2 ) and pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α and interleukins (ILs). However, vigorous production of inflammatory cytokines may lead to septic shock and tissue damage during an infection (2, 3) .
Production and release of pro-inflammatory mediators and cytokines in response to LPS is dependent upon inducible gene expression, which is mediated by the activation of transcription factors including nuclear transcription factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) (4) (5) (6) (7) (8) . NF-κB regulates various genes involved in immune and acute phase inflammatory responses. NF-κB activation, in response to pro-inflammatory stimuli, involves the rapid phosphorylation of IκB by the IκB kinase (IKK) signalosome complex. Free NF-κB produced by this process is translocated to the nucleus where it binds to κB-binding sites in the promoter regions of target genes. It then induces the transcription of pro-signalosome mediators and cytokines (9) (10) (11) . Therefore, the NF-κB activation pathway is a common target of antiinflammatory drugs.
Effective herbal medicines have recently generated renewed interest for the production of novel therapeutic . 1A) , isolated from H. fusiforme extracts, potently induces apoptosis in human AGS carcinoma cells (19) . In addition, 5HHMF and its derivative 3'-hydrox y-5,6,7,4'-tetramethoxyflavone, exhibit more potent inhibitory effects on the growth of human leukemia and breast cancer cells than their permethoxylated counterparts, HMF and 5,6,7,3',4'-pentamethoxyflavone, respectively (20, 21) . However, the anti-inflammatory activity of 5HHMF has not yet been elucidated. The aim of the present study was to investigate whether 5HHMF inhibited the production and expression of inflammatory mediators and cytokines in LPS-stimulated RAW 264.7 murine macrophage cells. To the best of our knowledge, this is the first study to investigate this and the results demonstrated that the anti-inflammatory effects of 5HHMF are achieved by inhibition of the nuclear translocation of NF-κB by preventing IκB-α degradation.
Materials and methods
Reagents. LPS (Escherichia coli 026:B6), Griess reagent, Tween-20, bovine serum albumin and MTT were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS) and other tissue culture reagents were purchased from Gibco-BRL (Grand Island, NY, USA). Other chemicals were obtained from Sigma-Aldrich unless otherwise indicated.
Cell culture. The RAW 264.7 cell line, which was derived from murine macrophages, was obtained from the American Type Culture Collection (Manassas, VA, USA). These cells were maintained in DMEM medium, supplemented with 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin, at 37˚C in a 5% CO 2 humidified air environment. Previously purified 5HHMF (19) was used in this study. The 5HHMF was dissolved in dimethyl sulfoxide (DMSO) to produce a 10 mg/ ml stock solution and then adjusted to final concentrations using complete DMEM.
Cell viability assay. Cell viability was evaluated by the MTT assay. RAW 264.7 cells were seeded into 96-well plates at a density of 4x10 3 cells/well and maintained at 37˚C for 24 h. The cells were exposed to various concentrations of 5HHMF (0, 5, 10 and 15 µg/ml) for 1 h and stimulated with LPS (100 ng/ml). After 24 h of incubation, the MTT (0.5 mg/ml in phosphate-buffered saline, PBS) solution was added to each well and incubated for another 3 h. The formazan crystals were dissolved in 200 µl DMSO and the cell viability was determined subsequent to measuring the absorbance at a wavelength of 540 nm with a microplate reader (Dynatech MR-7000; Dynatech Laboratories Inc., Chantilly, VA, USA).
Measurement of NO and PGE 2 production. The nitrite concentration in the medium was measured according to the Griess reaction and the calculated concentration was taken as an indicator of NO production. The supernatant of cell cultures was mixed with an equal volume of Griess reagent (1% sulfanilamide in 5% phosphoric acid and 0.1% naphthylethylenediamine dihydrochloride in water). The optical density at 540 nm was measured and calculated against a sodium nitrite standard curve. The accumulated PGE 2 in the culture medium was measured using a PGE 2 enzyme-linked immunosorbent assay (ELISA) kit (Cayman Chemical, Ann Arbor, MI, USA), according to the manufacturer's instructions.
Measurement of pro-inflammatory cytokine production. The inhibitory effect of 5HHMF on the production of pro-inflammatory cytokines, TNF-α and IL-1β, from LPS-treated RAW 264.7 cells was determined using a mouse ELISA kit (R&D Systems, Minneapolis, MN, USA), as described previously (22) .
Reverse transcriptase PCR (RT-PCR).
Total RNA was isolated using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA). The total RNA (1 µg) obtained from the cells was reverse-transcribed using M-MLV Reverse Transcriptase (Promega Corporation, Madison, WI, USA) to produce cDNA. RT-generated cDNA encoding iNOS, COX-2, TNF-α, IL-1β and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) genes was amplified by PCR using selective primers (Table I) . Subsequent to amplification, aliquots of the PCR reaction mixture were electrophoresed on an agarose gel.
Western blot analysis. The cells were washed with PBS three times and lysed with a lysis buffer (1% Triton X-100, 1% deoxycholate and 0.1% NaN 3 ) containing protease inhibitor cocktail tablets (Roche Diagnostics GmbH, Mannheim, Germany). Equal quantities of protein were separated on 10% sodium dodecyl sulfate-polyacrylamide mini-gels and transferred to Immobilon polyvinylidene difluoride membranes (Millipore, Milford, MA, USA). Subsequent to incubation with the appropriate primary antibody, the membrane was hybridized with secondary antibody conjugated to horseradish peroxidase for 1 h at room temperature. Following three washes with Tris-buffered saline with Tween-20, immunoreactive bands were visualized using the Enhanced Chemiluminescence Detection system (Pierce Biotechnology Inc., Rockford, IL, USA). In a parallel experiment, nuclear protein was prepared using nuclear extraction reagents (Pierce Biotechnology Inc.), according to the manufacturer's instructions.
Confocal laser scanning microscopy study. NF-κB p65 nuclear localization was detected by indirect immunofluorescence assays using confocal microscopy. RAW 264.7 cells were cultured directly on glass coverslips in 6-well plates for 24 h. Subsequent to stimulation with 100 ng/ml LPS and/or 15 µg/ml 5HHMF, the cells were fixed with 4% paraformaldehyde in PBS, permeabilized with 0.2% Triton X-100 in PBS and blocked with 1.5% normal donkey serum (Sigma-Aldrich). A polyclonal antibody against NF-κB p65 (1 µg/well) was applied for 1 h followed by a 1 h incubation with fluorescein isothiocyanate-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). After washing with PBS, the coverslips were mounted in Fluoromount-G™ (Southern Biotechnology Associates Inc., Birmingham, AL, USA) and fluorescence was visualized using a Zeiss LSM 510 laser scanning confocal device attached to an Axiovert 100 microscope using a Plan-Apochromat x100 Oil DIC objective (Carl Zeiss, Oberkochen, Germany) (23) .
Statistical analysis. Data are presented as the mean ± SD. Statistical significance was determined using analysis of variance followed by Student's t-test. P<0.05 was considered to indicate a statistically significant difference.
Results
Protective effect of 5HHMF on LPS-induced cytotoxicity. The protective effect of 5HHMF was initially investigated based on LPS-induced cytotoxicity of RAW 264.7 cells using an MTT assay. As shown in Fig. 1C , LPS (100 ng/ml) treatment significantly induced cytotoxicity compared with that observed in the unstimulated control cells. However, the growth of LPS-stimulated RAW 264.7 cells was significantly enhanced by 5HHMF in a dose-dependent manner. Moreover, 5, 10 and 15 µg/ml concentrations of 5HHMF exhibited a protective effect on LPS-stimulated cytotoxicity in RAW 264.7 cells. However, 5HHMF alone did not show any obvious cytotoxic effect at the concentrations of 5-15 µg/ml (Fig. 1B) .
Effect of 5HHMF on NO and PGE 2 production in LPS-stimulated RAW 264.7 cells. Pro-inflammatory mediators such as NO and PGE 2 are important in the inflammatory response. To determine the level of NO production, nitrite released into the culture medium was measured using Griess reagent. As shown in Fig. 2A , LPS alone markedly 
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A induced NO production in the cells compared with that in the control. However, pre-treatment with 5HHMF (up to 15 µg/ ml) significantly repressed the levels of NO production in LPS-stimulated RAW 264.7 cells in a concentration-dependent manner ( Fig. 2A) . The effects of 5HHMF on the production of PGE 2 , another important inflammatory mediator, was also investigated in LPS-stimulated RAW 264.7 cells. As shown in Fig. 2B , treatment of RAW 264.7 cells with LPS resulted in a marked increase in PGE 2 release compared with that in the untreated control after 24 h of exposure to LPS. However, 5HHMF inhibited LPS-mediated PGE 2 production in a concentration-dependent manner at the concentrations tested. These results suggest that pretreatment with 5HHMF results in significant suppression of the expression of LPS-mediated pro-inflammatory mediators.
Effect of 5HHMF on LPS-stimulated iNOS and COX-2 expression.
To elucidate the mechanism involved in the inhibition of NO and PGE 2 by 5HHMF in LPS-stimulated RAW 264.7 cells, the effect of 5HHMF on iNOS and COX-2 protein and gene expression levels was investigated by western blot and RT-PCR analyses (Fig. 3) . iNOS and COX-2 protein and mRNA expression in unstimulated RAW 264.7 cells was marginally detectable. However, iNOS and COX-2 expression increased markedly in response to LPS, and 5HHMF significantly inhibited the iNOS and COX-2 proteins in a dose-dependent manner (Fig. 3A) . Under the same conditions, the levels of iNOS and COX-2 mRNA expression were correlated with their protein levels (Fig. 3B) . These results indicated that reduced expression of iNOS and COX-2 by 5HHMF was responsible for inhibiting NO and PGE 2 production.
Effect of 5HHMF on TNF-α and IL-1β production and expression in LPS-stimulated RAW 264.7 cells.
As 5HHMF potently inhibited the pro-inflammatory mediators NO and PGE 2 , its effects on LPS-stimulated pro-inflammatory cytokines, such as TNF-α and IL-1β, were investigated by an enzyme immunoassay and RT-PCR analysis. As shown in Fig. 4A and B, TNF-α and IL-1β levels increased significantly in the culture media of LPS-stimulated RAW 264.7 cells. However, pre-treatment with 5HHMF significantly decreased the release of these pro-inflammatory cytokines in a concentration-dependent manner. In addition, the TNF-α and IL-1β mRNA levels induced by LPS decreased significantly in a concentration-dependent manner following 5HHMF treatment (Fig. 4C) . These results suggested that 5HHMF is effective in suppressing pro-inflammatory cytokine production by altering TNF-α and IL-1β transcription levels in activated RAW 264.7 cells.
Inhibition of NF-κB activation by 5HHMF in LPS-stimulated RAW 264.7 cells.
Previous studies have suggested that NF-κB is an important transcription factor that regulates iNOS, COX-2 and inflammatory cytokine expression (24, 25) . A number of the predominant mechanisms involving the activation of NF-κB include the phosphorylation of IKK and degradation of IκB-α, which allow the release of free NF-κB and its translocation into the nucleus (26) . To investigate whether 5HHMF regulates the NF-κB pathway, we investigated whether 5HHMF prevented the translocation of the NF-κB p65 subunit to the nucleus. Western blot analysis showed that macrophage cells were pre-treated with 5HHMF (5, 10 and 15 µg/ml) 1 h prior to incubation with LPS (100 ng/ml) for 24 h. Cell lysates were then prepared and western blot analysis was performed using antibodies specific for murine iNOS and COX-2. (B) Total RNA was prepared for reverse transcriptase PCR analysis of iNOS and COX-2 gene expression in LPS-stimulated RAW 264.7 cells. Actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were used as internal controls for the western blot and reverse transcriptase PCR analyses, respectively. The experiment was repeated three times and similar results were obtained.
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A the quantity of NF-κB p65 in the nucleus increased markedly following exposure to LPS alone; however, the LPS-induced p65 level in the nuclear fractions decreased following 5HHMF pre-treatment. In addition, western blot analysis was used to investigate whether 5HHMF blocked LPS-stimulated degradation of IκB-α. As shown in Fig. 5A , IκB-α was markedly degraded 15 min after LPS treatment. This LPS-induced IκB-α degradation was significantly reversed by 5HHMF.
Furthermore, the translocation of NF-κB to the nucleus in RAW 264.7 cells was analyzed using immunofluorescence staining and confocal microscopy to clearly understand the effect of 5HHMF on NF-κB p65 nuclear translocation (Fig. 5B) . The confocal images revealed that NF-κB p65 was normally sequestered in the cytoplasm (Fig. 5B, middle  panel) , and that nuclear accumulation of NF-κB p65 was markedly induced following the stimulation of RAW 264.7 (A) Cells were treated with 5HHMF (5, 10 and 15 µg/ml) for 1 h prior to LPS treatment (100 ng/ml) for 15 min. Equal quantities of protein were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by western blot analysis using anti-NF-κB p65 and IκB-α. Results are representative of those obtained from three independent experiments. (B) RAW 264.7 macrophage cells were pre-treated with 15 µg/ml 5HHMF for 1 h prior to stimulation with LPS (100 ng/ml) for 1 h. p65 protein localization was determined using an anti-p65 antibody and fluorescein isothiocyanate-labeled anti-rabbit IgG antibody and cells were visualized using laser confocal scanning microscopy. Representative results of three independent experiments are shown. (Fig. 5B, LPS panel) . The LPS-induced translocation of NF-κB p65 was completely eliminated subsequent to pre-treating the cells with 5HHMF (Fig. 5B, LPS+5HHMF  panel) . Nuclear translocation of NF-κB p65 was not induced in the cells following pre-treatment with 5HHMF alone, in the absence of LPS stimulation (Fig. 5B, 5HHMF panel) . Thus, these results demonstrated that the anti-inflammatory effect of 5HHMF in LPS-stimulated RAW 264.7 cells involves the NF-κB pathway.
Discussion
The results of ther present study have demonstrated that 5HHMF exhibits pharmacological and biological activities via significant inhibitory effects on the production of the LPS-induced pro-inflammatory mediators, such as iNOS and COX-2, as well as cytokines (including TNF-α and IL-1β) in activated RAW 264.7 cells. These effects were accompanied by the downregulation of NF-κB activation.
Macrophages produce NO and pro-inf lammatory cytokines in response to bacterial LPS. This NO production is controlled by selective pharmacological inhibition of distinct NO synthase isoforms (27, 28) . iNOS is one of three key enzymes that generate NO from arginine. NO is pivotal in numerous body functions; however, its overproduction in macrophages, in particular, leads to cytotoxicity, inflammation and autoimmune disorders (6) . Therefore, NO inhibitors are essential for preventing inflammatory diseases. PGE 2 is considered an important mediator in the processes of inflammation produced by COX-2 (29) . As a result, a detailed understanding of the intracellular mechanisms of the expression of inflammatory mediators and the effects of inhibiting those inflammatory mediators is important to identify therapeutic strategies for inflammatory diseases. In the present study, 5HHMF significantly suppressed LPS-stimulated NO and PGE 2 production in RAW 264.7 cells in a concentration-dependent manner, which appeared to be due to the transcriptional suppression of COX-2 and iNOS. The results of the present study also indicated that 5HHMF suppressed the production of the pro-inflammatory cytokines TNF-α and IL-1β. These cytokines are key in the induction of inflammation in macrophages (28, 30) . TNF-α exhibits its pro-inflammatory activity by regulating several intercellular and vascular cell adhesion molecules, which results in the recruitment of leukocytes to sites of inflammation (31) . IL-1β is also a key pro-inflammatory cytokine that is released from immune responding cells when stimulated by LPS (32) . Thus, inhibition of cytokine production or function may be considered a key mechanism in RAW 264.7 cells. Treatment with 5HHMF prior to LPS stimulation significantly attenuated the production of cytokines in RAW 264.7 cells. Therefore, the inhibitory effect of 5HHMF on inflammatory mediator expression aided in the identification of one of the mechanisms responsible for its anti-inflammatory action and suggests that 5HHMF is a potential therapeutic agent for treating LPS-induced sepsis syndrome.
Bacterial pathogens such as LPS stimulate the transcription of genes involved in the inflammatory and immune responses, including the NF-κB pathway (33) . NF-κB is activated by phosphorylation, ubiquitination and subsequent proteolytic degradation of NF-κB-bound IκB via activated IκB kinase (34) . The excreted NF-κB transcription factor then translocates to the nucleus and binds to NF-κB motifs in the promoters of target genes such as those encoding iNOS, COX-2 and cytokines to promote transcription (35) . The results of the present study suggest that 5HHMF significantly inhibits the LPS-stimulated nuclear translocation of p65 in RAW 264.7 macrophages. Thus, the potential inhibition of cytokine production by 5HHMF is in accordance with the inhibition of NF-κB-dependent cytokines and reduced inflammation. Although inhibiting NF-κB activation has been proposed as a therapeutic approach for sepsis, NF-κB is an essential component of normal host defenses and blocking the regulatory actions of NF-κB may result in severe immunosuppression (36) .
In conclusion, the results of the present study have demonstrated that 5HHMF treatment results in a decrease of pro-inflammatory mediators following LPS stimulation in RAW 264.7 cells. 5HHMF also significantly inhibited the release of TNF-α and IL-1β and decreased their mRNA expression levels in a dose-dependent manner. In addition, the anti-inflammatory properties of 5HHMF were mediated by the downregulation of NF-κB activation. Therefore, 5HHMF is a potential therapeutic agent for patients with, or at risk of, septic shock and other inflammatory diseases.
